Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v3-EN
Language French English
Date Updated 2022-08-09 2022-04-06
Drug Identification Number 02237820 02237820
Brand name AMERGE AMERGE
Common or Proper name Naratriptan Tablets Naratriptan Tablets
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients NARATRIPTAN NARATRIPTAN
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size All pack sizes/ Tous les formats All pack sizes/ Tous les formats
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-07-29
Actual discontinuation date 2022-08-05
Remaining supply date 2024-02-17 2024-02-17
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments